0001209191-20-037731.txt : 20200618
0001209191-20-037731.hdr.sgml : 20200618
20200618211927
ACCESSION NUMBER: 0001209191-20-037731
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200618
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
CENTRAL INDEX KEY: 0001787092
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39333
FILM NUMBER: 20974056
BUSINESS ADDRESS:
STREET 1: WELLINGTON ALTERNATIVE INVESTMENTS LLC
STREET 2: 280 CONGRESS STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (617) 951-5372
MAIL ADDRESS:
STREET 1: WELLINGTON ALTERNATIVE INVESTMENTS LLC
STREET 2: 280 CONGRESS STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forma Therapeutics Holdings, Inc.,
CENTRAL INDEX KEY: 0001538927
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 371657129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
STREET 2: SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-679-1970
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
STREET 2: SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Forma Therapeutics Holdings LLC
DATE OF NAME CHANGE: 20120106
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-06-18
0
0001538927
Forma Therapeutics Holdings, Inc.,
FMTX
0001787092
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
WELLINGTON ALTERNATIVE INVESTMENTS LLC
280 CONGRESS STREET
BOSTON
MA
02210
0
0
1
0
Series D Convertible Preferred Stock
Common Stock
1252913
D
Each share of Series D Preferred Stock is convertible at any time, at the Reporting Person's election, into Common Stock, on a 4.2775-for-one basis into the number of shares of common stock shown in column 3, has no expiration date and will convert automatically into shares of Common Stock upon the closing of the Issuer's initial public offering.
Wellington Biomedical Innovation Master Investors
(Cayman) I L.P., By: Wellington Management Company
LLP, as investment advisor, /s/ Matthew N. Shea, Title: Authorized Person
2020-06-18